BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26077913)

  • 21. The extent of extrathyroidal extension is a key determinant of prognosis in T4a papillary thyroid cancer.
    Abraham E; Roshan D; Tran B; Wykes J; Campbell P; Ebrahimi A
    J Surg Oncol; 2019 Nov; 120(6):1016-1022. PubMed ID: 31452204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
    Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival.
    Ito Y; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
    World J Surg; 2006 May; 30(5):780-6. PubMed ID: 16411013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Papillary thyroid carcinoma: different clinical behavior among pT3 tumors.
    Santos MJ; Bugalho MJ
    Endocrine; 2016 Sep; 53(3):754-60. PubMed ID: 27000081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
    Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of tumor size and focality with recurrence/persistence in papillary thyroid cancer patients treated with total thyroidectomy along with radioactive-iodine ablation and TSH suppression.
    Khan M; Syed AA; Khan AI; Hussain SR; Urooj N
    Updates Surg; 2018 Mar; 70(1):121-127. PubMed ID: 28550398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is Male Gender a Prognostic Factor for Papillary Thyroid Microcarcinoma?
    Lee YH; Lee YM; Sung TY; Yoon JH; Song DE; Kim TY; Baek JH; Ryu JS; Chung KW; Hong SJ
    Ann Surg Oncol; 2017 Jul; 24(7):1958-1964. PubMed ID: 28130621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications.
    Ghossein RA; Leboeuf R; Patel KN; Rivera M; Katabi N; Carlson DL; Tallini G; Shaha A; Singh B; Tuttle RM
    Thyroid; 2007 Jul; 17(7):655-61. PubMed ID: 17696836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Papillary Thyroid Cancers of the Thyroid Isthmus: The Pattern of Nodal Metastasis and the Significance of Extrathyroidal Extension.
    Seok J; Choi JY; Yu HW; Jung YH; Ahn SH; Jeong WJ
    Ann Surg Oncol; 2020 Jun; 27(6):1937-1944. PubMed ID: 31970571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
    Furlan JC; Bedard YC; Rosen IB
    J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in the characteristics of papillary thyroid microcarcinoma ≤5 mm and >5 mm in diameter.
    Kim E; Choi JY; Koo do H; Lee KE; Youn YK
    Head Neck; 2015 May; 37(5):694-7. PubMed ID: 24596325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in the Recurrence and Survival of Patients with Symptomatic and Asymptomatic Papillary Thyroid Carcinoma: An Observational Study of 11,265 Person-Years of Follow-Up.
    Kim SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Thyroid; 2016 Oct; 26(10):1472-1479. PubMed ID: 27457917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low serum 25 hydroxyvitamin D is associated with poor clinicopathologic characteristics in female patients with papillary thyroid cancer.
    Kim JR; Kim BH; Kim SM; Oh MY; Kim WJ; Jeon YK; Kim SS; Lee BJ; Kim YK; Kim IJ
    Thyroid; 2014 Nov; 24(11):1618-24. PubMed ID: 25133449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extrathyroidal Extension: Does Strap Muscle Invasion Alone Influence Recurrence and Survival in Patients with Differentiated Thyroid Cancer?
    Amit M; Boonsripitayanon M; Goepfert RP; Tam S; Busaidy NL; Cabanillas ME; Dadu R; Varghese J; Waguespack SG; Gross ND; Graham P; Williams MD; Sturgis EM; Zafereo ME
    Ann Surg Oncol; 2018 Oct; 25(11):3380-3388. PubMed ID: 30022274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Prognosis of Papillary Thyroid Cancer with Initial Distant Metastasis is Strongly Associated with Extensive Extrathyroidal Extension: A Retrospective Cohort Study.
    Lee YK; Kim D; Shin DY; Lee CR; Lee EJ; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY; Park CS
    Ann Surg Oncol; 2019 Jul; 26(7):2200-2209. PubMed ID: 30895495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric patients with multifocal papillary thyroid cancer have higher recurrence rates than adult patients: a retrospective analysis of a large pediatric thyroid cancer cohort over 33 years.
    Lee YA; Jung HW; Kim HY; Choi H; Kim HY; Hah JH; Park DJ; Chung JK; Yang SW; Shin CH; Park YJ
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1619-29. PubMed ID: 25632969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
    Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
    Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is There a Difference Between Minimal and Gross Extension into the Strap Muscles for the Risk of Recurrence in Papillary Thyroid Carcinomas?
    Danilovic DLS; Castroneves LA; Suemoto CK; Elias LO; Soares IC; Camargo RY; Correa FA; Hoff AO; Marui S
    Thyroid; 2020 Jul; 30(7):1008-1016. PubMed ID: 32059626
    [No Abstract]   [Full Text] [Related]  

  • 39. [Non-incidental papillary microcarcinomas of the thyroid].
    Monteros Alvi M; Gonorazky S; Virgili E; Soler G; Fernández M; van Cauwlaert L
    Medicina (B Aires); 2008; 68(2):139-43. PubMed ID: 18499963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer.
    Dai L; Wang Y; Chen L; Zheng J; Li J; Wu X
    World J Surg Oncol; 2017 Jan; 15(1):11. PubMed ID: 28061868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.